These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28921760)

  • 1. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
    Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
    Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
    Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
    Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans.
    Chenoweth MJ; Cox LS; Nollen NL; Ahluwalia JS; Benowitz NL; Lerman C; Knight J; Tyndale RF
    Sci Rep; 2021 Oct; 11(1):19572. PubMed ID: 34599228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
    Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
    PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent.
    Buchwald J; Chenoweth MJ; Palviainen T; Zhu G; Benner C; Gordon S; Korhonen T; Ripatti S; Madden PAF; Lehtimäki T; Raitakari OT; Salomaa V; Rose RJ; George TP; Lerman C; Pirinen M; Martin NG; Kaprio J; Loukola A; Tyndale RF
    Mol Psychiatry; 2021 Jun; 26(6):2212-2223. PubMed ID: 32157176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.
    El-Boraie A; Taghavi T; Chenoweth MJ; Fukunaga K; Mushiroda T; Kubo M; Lerman C; Nollen NL; Benowitz NL; Tyndale RF
    Addict Biol; 2020 Jan; 25(1):e12741. PubMed ID: 30815984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
    Chenoweth MJ; Novalen M; Hawk LW; Schnoll RA; George TP; Cinciripini PM; Lerman C; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1773-82. PubMed ID: 25012994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
    Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
    Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
    Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS
    Trials; 2011 Jan; 12():22. PubMed ID: 21266057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
    Murphy SE; Sipe CJ; Choi K; Raddatz LM; Koopmeiners JS; Donny EC; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1093-1099. PubMed ID: 28264876
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
    Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
    Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers.
    Pouget JG; Giratallah H; Langlois AWR; El-Boraie A; Lerman C; Knight J; Cox LS; Nollen NL; Ahluwalia JS; Benner C; Chenoweth MJ; Tyndale RF
    Mol Psychiatry; 2024 Aug; ():. PubMed ID: 39217253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.
    El-Boraie A; Chenoweth MJ; Pouget JG; Benowitz NL; Fukunaga K; Mushiroda T; Kubo M; Nollen NL; Sanderson Cox L; Lerman C; Knight J; Tyndale RF
    Clin Pharmacol Ther; 2021 Oct; 110(4):975-985. PubMed ID: 33300144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CYP2A6 Activity on Nicotine Reinforcement and Cue-Reactivity in Daily Smokers.
    Butler K; Chenoweth MJ; El-Boraie A; Giratallah H; Kowalczyk WJ; Heishman SJ; Tyndale RF; Le Foll B
    Nicotine Tob Res; 2021 Aug; 23(10):1735-1743. PubMed ID: 33823003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
    Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.
    Ross KC; Gubner NR; Tyndale RF; Hawk LW; Lerman C; George TP; Cinciripini P; Schnoll RA; Benowitz NL
    Pharmacol Biochem Behav; 2016 Sep; 148():1-7. PubMed ID: 27180107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
    Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
    PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
    Taghavi T; St Helen G; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking.
    Mwenifumbo JC; Sellers EM; Tyndale RF
    Drug Alcohol Depend; 2007 Jun; 89(1):24-33. PubMed ID: 17161559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.
    Lutz SM; Frederiksen B; Begum F; McDonald MN; Cho MH; Hobbs BD; Parker MM; DeMeo DL; Hersh CP; Ehringer MA; Young K; Jiang L; Foreman MG; Kinney GL; Make BJ; Lomas DA; Bakke P; Gulsvik A; Crapo JD; Silverman EK; Beaty TH; Hokanson JE;
    Nicotine Tob Res; 2019 May; 21(6):714-722. PubMed ID: 29767774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.